| Product Code: ETC13307242 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Cell Gene Therapy Manufacturing Market was valued at USD 6.7 Billion in 2024 and is expected to reach USD 17.9 Billion by 2031, growing at a compound annual growth rate of 10.30% during the forecast period (2025-2031).
The Global Cell Gene Therapy Manufacturing Market is witnessing significant growth due to the rising demand for personalized medicines and innovative treatment options. The market encompasses the manufacturing processes involved in producing cell and gene therapies, including viral vector production, cell expansion, purification, and formulation. Key factors driving the market include advancements in biotechnology, increasing investments in research and development, and regulatory support for cell and gene therapy products. Companies are investing in expanding their manufacturing capabilities, implementing automation and process optimization technologies to meet the growing demand for these cutting-edge therapies. The market is characterized by collaborations between pharmaceutical companies, contract manufacturing organizations, and research institutions to accelerate the development and commercialization of cell and gene therapy products. Overall, the Global Cell Gene Therapy Manufacturing Market is poised for robust growth in the coming years.
The Global Cell Gene Therapy Manufacturing Market is experiencing significant growth driven by increasing R&D investments, advancements in technology, and rising prevalence of chronic diseases. One major trend is the shift towards personalized medicine, leading to the development of more targeted and effective cell and gene therapies. Opportunities lie in expanding manufacturing capacity to meet growing demand, enhancing process efficiencies through automation and digitalization, and developing novel therapies for a wide range of diseases. Collaboration between industry players, academic institutions, and regulatory bodies is crucial to address manufacturing challenges and ensure the successful commercialization of cell and gene therapies. Overall, the market is poised for continued expansion and innovation as companies strive to bring transformative treatments to patients worldwide.
One of the key challenges faced in the Global Cell Gene Therapy Manufacturing Market is the complex and costly manufacturing processes involved in producing these innovative therapies. The personalized and precise nature of cell and gene therapies often requires specialized facilities, equipment, and expertise, which can lead to high production costs and limited scalability. Additionally, ensuring consistent quality control and adhering to stringent regulatory requirements adds another layer of complexity to the manufacturing process. As the demand for these therapies continues to grow, manufacturers are under pressure to optimize production efficiencies, reduce costs, and overcome logistical hurdles to meet the evolving needs of patients and healthcare providers worldwide. Collaboration between industry stakeholders, regulators, and investors will be crucial in addressing these challenges and advancing the accessibility and affordability of cell and gene therapies.
The Global Cell Gene Therapy Manufacturing Market is primarily driven by the increasing prevalence of genetic disorders and chronic diseases, leading to a growing demand for personalized and advanced treatment options. Technological advancements in cell and gene therapy manufacturing processes, such as automation and scalability, are also fueling market growth by improving efficiency and reducing production costs. Additionally, supportive government initiatives and regulatory approvals for cell and gene therapy products are boosting market expansion. Furthermore, collaborations between pharmaceutical companies and research institutions to develop innovative therapies, along with investments in infrastructure and facilities for manufacturing these therapies, are key factors driving the global market forward.
Government policies related to the Global Cell Gene Therapy Manufacturing Market vary by country, but common themes include regulatory frameworks to ensure safety and efficacy of products, financial incentives to support research and development, and measures to streamline approval processes. In the United States, the FDA`s expedited programs like the Regenerative Medicine Advanced Therapy (RMAT) designation aim to accelerate the development and approval of cell and gene therapies. In the European Union, the Advanced Therapy Medicinal Products (ATMP) regulations provide a centralized approval process for these innovative therapies. Additionally, governments worldwide are investing in infrastructure and workforce development to support the growth of the cell gene therapy manufacturing sector. Overall, these policies aim to foster innovation, ensure patient access to cutting-edge therapies, and maintain high standards of quality and safety in the market.
The Global Cell Gene Therapy Manufacturing Market is poised for significant growth in the coming years as advancements in biotechnology and healthcare continue to drive innovation in this field. With an increasing number of gene therapy products entering the market and a growing demand for personalized medicine, the manufacturing sector is expected to expand rapidly to meet these needs. Factors such as improved regulatory frameworks, technological developments, and investments in research and development are contributing to the positive outlook for the market. Additionally, the shift towards more efficient and scalable manufacturing processes is anticipated to further drive growth and drive down costs, making cell gene therapy more accessible to a broader patient population around the world.
In the Global Cell Gene Therapy Manufacturing Market, Asia is emerging as a key region for manufacturing due to its cost advantages and growing infrastructure. North America remains a major player with advanced manufacturing capabilities and a strong regulatory framework. Europe is also a significant market with established expertise in cell and gene therapy manufacturing. In the Middle East and Africa, there is a growing interest in developing manufacturing capabilities, although at a slower pace compared to other regions. Latin America is witnessing increasing investment in cell and gene therapy manufacturing facilities, driven by a growing demand for advanced medical treatments in the region. Overall, the global cell gene therapy manufacturing market is experiencing growth across all regions, with each offering unique opportunities and challenges for industry players.
Global Cell Gene Therapy Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Cell Gene Therapy Manufacturing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Global Cell Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Global Cell Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Global Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.8 Global Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Cell Gene Therapy Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Cell Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Cell Gene Therapy Manufacturing Market Trends |
6 Global Cell Gene Therapy Manufacturing Market, 2021 - 2031 |
6.1 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cell Expansion Systems, 2021 - 2031 |
6.1.3 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Gene Editing Platforms, 2021 - 2031 |
6.1.4 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cryopreservation Solutions, 2021 - 2031 |
6.1.5 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Fill-Finish Services, 2021 - 2031 |
6.2 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Bioreactor-Based Expansion, 2021 - 2031 |
6.2.3 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Zinc Finger Nucleases, 2021 - 2031 |
6.2.4 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Liquid Nitrogen Storage, 2021 - 2031 |
6.2.5 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Sterile Filling and Packaging, 2021 - 2031 |
6.3 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By CDMOs and Pharma Companies, 2021 - 2031 |
6.3.3 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Research Laboratories, 2021 - 2031 |
6.3.4 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Cell Banks and Biorepositories, 2021 - 2031 |
6.3.5 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Hospitals and Clinical Centers, 2021 - 2031 |
6.4 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Scalable Cell Therapy Manufacturing, 2021 - 2031 |
6.4.3 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Genetic Modification for Therapies, 2021 - 2031 |
6.4.4 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Long-Term Storage of CGT Products, 2021 - 2031 |
6.4.5 Global Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Final Product Delivery to Patients, 2021 - 2031 |
7 North America Cell Gene Therapy Manufacturing Market, Overview & Analysis |
7.1 North America Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
7.2 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.5 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Overview & Analysis |
8.1 Latin America (LATAM) Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
8.5 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Cell Gene Therapy Manufacturing Market, Overview & Analysis |
9.1 Asia Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
9.5 Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Cell Gene Therapy Manufacturing Market, Overview & Analysis |
10.1 Africa Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
10.5 Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Cell Gene Therapy Manufacturing Market, Overview & Analysis |
11.1 Europe Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
11.5 Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Cell Gene Therapy Manufacturing Market, Overview & Analysis |
12.1 Middle East Cell Gene Therapy Manufacturing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Cell Gene Therapy Manufacturing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
12.5 Middle East Cell Gene Therapy Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Cell Gene Therapy Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Cell Gene Therapy Manufacturing Market Key Performance Indicators |
14 Global Cell Gene Therapy Manufacturing Market - Export/Import By Countries Assessment |
15 Global Cell Gene Therapy Manufacturing Market - Opportunity Assessment |
15.1 Global Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
15.4 Global Cell Gene Therapy Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Cell Gene Therapy Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Cell Gene Therapy Manufacturing Market - Competitive Landscape |
16.1 Global Cell Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
16.2 Global Cell Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here